• |
  • Search
  • |
  • Contact Us
The Bayer Cross
Skip navigation links
Product/Service Info
Products
Services
 
product overview product details photos specifications Safety-Information
 
AngioJet XMI Thrombectomy action 
 

Reduced Complications and Improved Procedure Success

AngioJet Thrombectomy as an adjunct to PCI, has been proven to:

  • Increase procedural success rates†
  • Reduce distal embolization†
  • Lower MACE rates by 50%†
  • Shorten length of stay by one day††

XMI Features

Compatible with 6F Systems

  • Low profile design allows deliverability and visualization through 6F systems

Tapered Tip Design

  • Excellent crossability for accessing tight lesions
  • Reduced potential for embolization during crossing

† AM ∫ Cardiol 2002; 89(3) 326-330
†† AM Heart ∫ 2001; 142:648-656


©2012 MEDRAD, INC. All rights reserved.  | About MEDRAD  | Site Map  | Contact Us  | Legal Notices  | California Transparency Act